- AmerisourceBergen Drug, now known as Cencora (NYSE:COR) awarded an estimated ~$2B modification extending the third two-year six-month option period of a two-year six-month base contract with three two-year six-month option periods for prime vendor pharmaceutical and pharmaceutical-related products and